Use of AMP to Improve Tissue Delivery of Adenosine
Ischemia
Enrolment: 13 · Results not recorded
Drug · Unknown
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Ischemia
Enrolment: 13 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute liver failure induced by intraperitoneal D-galactosamine 500 mg/kg plus lipopolysaccharide (serotype O55:B5) 5 micrograms/kg
5'-AMP pre-treatment raised survival from 33.3% to 93.3% at 24 hours (log-rank P = 0.0007), lowered serum AST and ALT, reduced hepatocyte necrosis and inflammatory cell infiltration, and cut cytokine and chemokine production. Protection persisted in adenosine receptor knockout mice, showing recepto…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.